The Pharmacovigilance and Drug Safety Software Market Size was valued at USD 6.83 billion in 2022, and is expected to reach USD 14.86 billion by 2030, and grow at a CAGR of 10.2% over the forecast period 2023-2030.
To identify, evaluate, comprehend, and prevent harmful effects associated to medications, medical devices, and pharmaceutical products, pharmacovigilance and drug safety software is utilised. Health organisations all around the world use it to guarantee compliance with international regulations, hasten the development of science-based safety judgments, combine safety and risk management, and reduce pharmacovigilance costs. To address the specific business and product safety needs of health businesses, service providers now deliver adaptable, creative, and scalable variations.
Get more information on Pharmacovigilance And Drug Safety Software Market - Request Sample Report
Pharmacovigilance, commonly referred to as drug safety, is the branch of research that focuses on identifying, evaluating, and preventing adverse effects of pharmaceuticals. The primary functions of pharmacovigilance and drug safety software are the creation, classification, and review of pharmacovigilance data, which increases healthcare workers' knowledge and awareness. The capability of the software is categorized into four categories: issue tracking, drug safety audits, adverse event reporting, and fully integrated software.
DRIVERS
Adverse Drug Reactions Are Now More Common.
Outsourcing Companies Are Using Pharmacovigilance Software More Frequently
RESTRAINTS
Pharmacovigilance is not widely known
OPPORTUNITIES
Increasing use of pharmaceutical monitoring software by outsourcing firms
the market is anticipated to grow due to the increased prevalence of chronic disorders.
CHALLENGES
Insufficiently qualified pharmacovigilance personnel
As a result of the COVID-19 epidemic, some businesses have introduced new issue tracking systems. For example, in May 2021, Dialog Solutions unveiled Drug Safety Triage, the pharmacovigilance literature monitoring system of the future. A new pharmacovigilance reporting platform for COVID-19 treatments was introduced in May 2020 by the Medicines and Healthcare Products Regulatory Agency under the name "Yellow Card COVID-19 reporting portal." In an effort to create a body of information about the safest ways to treat the disease, a new online reporting platform may monitor any negative effects resulting from the usage of any medicines used to treat COVID-19. As a result, the introduction of such a product can benefit the market sector in question.
By Functionality
The market is divided into four segments: issue tracking software, adverse event reporting software, and fully integrated software. The market share leader is the fully Integrated Software sector.
By Delivery
Market segments include on-premises delivery mode and on-demand/cloud delivery mode. The most notable CAGR in the foreseeable future is expected to be in the on-demand/cloud-based delivery mode.
By End-User
Contract research organizations (CROS), business process outsourcing (BPO) companies, pharmaceutical and biotechnology companies, and other pharmacovigilance service providers make up the two halves of the industry. Business Process Outsourcing (BPO) Companies are predicted to hold the biggest market share, followed by Contract Research Organizations (CROS).
By Functionality
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
By Delivery
On-Premise Delivery Mode
On-Demand/Cloud-Based
By End-User
Pharma and Biotech Companies
Contract Research Organizations (CROS)
Business Process Outsourcing (BPO) Firms
.png)
Need any customization research on Pharmacovigilance and Drug Safety Software Market - Enquiry Now
The market for pharmaceutical vigilance and drug safety software is divided into four regions: North America, Europe, Asia-Pacific, and the rest of the world (RoW). The market for pharmacovigilance and drug safety software is anticipated to be dominated by North America. Asia-Pacific is anticipated to grow at a quicker pace over the estimated period due to rising expenditure in the research & development process and acceptance of solutions in the area.
Increasing regional competition in the Pharmacovigilance and Drug Safety Software Market is anticipated to fuel future market expansion. Additionally, it is anticipated that during the research period, leading vendors will increase their investments in product capabilities and company expansion.
REGIONAL COVERAGE
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The Major key players are Aris Global, Capgemini, Accenture, Cognizant, IBM, Laboratory Corporation of America Holdings, Oracle, ICON Plc., Parexel International Corporation, IQVIA and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 6.83 Billion |
| Market Size by 2030 | US$ 14.86 Billion |
| CAGR | CAGR of 10.2% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software) • By Delivery (On-Premise Delivery Mode, On-Demand/Cloud-Based) • By End-User (Pharma and Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Aris Global, Capgemini, Accenture, Cognizant, IBM, Laboratory Corporation of America Holdings, Oracle, ICON Plc., Parexel International Corporation, IQVIA. |
| DRIVERS | • Adverse Drug Reactions Are Now More Common. • Outsourcing Companies Are Using Pharmacovigilance Software More Frequently |
| RESTRAINTS | • Pharmacovigilance is not widely known |
Ans: The Pharmacovigilance and Drug Safety Software market is expected to grow at a CAGR of 10.2% over the forecast period 2023-2030.
Pharmacovigilance is not widely known are the restraints of the market.
Pharmacovigilance and Drug Safety Software Market is divided into three segments and they are By Functionality, By Delivery, and By End-User
The market for pharmacovigilance and drug safety software is anticipated to be dominated by North America.
Ans: The Pharmacovigilance and Drug Safety Software Market size was valued at US$ 6.83 billion in 2022.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Pharmacovigilance and Drug Safety Software Market Segmentation, By Functionality
8.1 Adverse Event Reporting Software
8.2 Drug Safety Audits Software
8.3 Issue Tracking Software
8.4 Fully Integrated Software
9. Pharmacovigilance and Drug Safety Software Market Segmentation, By Delivery
9.1 On-Premise Delivery Mode
9.2 On-Demand/Cloud-Based
10. Pharmacovigilance and Drug Safety Software Market Segmentation, By End-User
10.1 Pharma and Biotech Companies
10.2 Contract Research Organizations (CROS)
10.3 Business Process Outsourcing (BPO) Firms
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Aris Global
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Capgemini
12.3 Accenture
12.4 Cognizant
12.5 IBM
12.6 Laboratory Corporation of America Holdings
12.7 Oracle
12.8 ICON Plc.
12.9 Parexel International Corporation
12.10 IQVIA
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Predictive Analytics Market was valued at USD 14.02 billion in 2023 and is expected to reach USD 126.15 billion by 2032, growing at a CAGR of 27.67% from 2024-2032.
The Urinary Catheters Market size was USD 3.91 billion in 2023 and is estimated to reach $6.32 billion by 2032 with a growing CAGR of 5.49% by 2024-2032.
The Pyrogen Testing Market Size was valued at USD 1.60 Billion in 2023 and is expected to reach USD 3.17 Billion by 2032, growing at a CAGR of 7.93% over the forecast period 2024-2032.
The Multimodal Imaging Market was valued at USD 4.43 billion in 2023 and is expected to reach USD 7.43 Billion by 2032, growing at a CAGR of 5.93% from 2024-2032.
The Single-cell Omics Market size was estimated at USD 1.61 billion in 2023 and is expected to reach USD 6.21 billion by 2032 with a growing CAGR of 16.2% during the forecast period of 2024-2032.
The Surgical Sutures Market size was projected at USD 4.55 billion in 2023 and is anticipated to reach USD 7.18 billion by 2032 at a CAGR of 5.2% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
